Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Tolerability Evaluation of Akkermansia Muciniphila
Sponsor: Wecare Probiotics Co., Ltd.
Summary
This is a randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of Akkermansia muciniphila Akk11 in healthy adult.
Official title: Safety and Tolerability Evaluation of Heat-Inactivated Akkermansia Muciniphila Akk11: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
108
Start Date
2025-11-25
Completion Date
2026-03-25
Last Updated
2025-07-29
Healthy Volunteers
Yes
Conditions
Interventions
Probiotic
The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).
Maltodextrin
The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).
Locations (1)
Fakultas Kedokteran Universitas Indonesia
Jakarta Pusat, Jakarta Special Capital Region, Indonesia